论文信息 - Bortezomib in relapsed or refractory mantle cell lymphoma (MCL): Results of the PINNACLE study. - 字舞流文

Bortezomib in relapsed or refractory mantle cell lymphoma (MCL): Results of the PINNACLE study.

R. Fisher | B. Djulbegovic | A. Boral | A. Goy | M. Robertson | S. Bernstein | B. Kahl | H. Shi